PetVision
Financiado
Next generation Limited-Angle time-of-flight PET imager
Over 2.7 million people in the EU were diagnosed with cancer in 2020, while 1.3 million people lost their lives to it. Cancer cases are predicted to increase by 24% by 2035, making it the leading cause of death in the EU. The curr...
Over 2.7 million people in the EU were diagnosed with cancer in 2020, while 1.3 million people lost their lives to it. Cancer cases are predicted to increase by 24% by 2035, making it the leading cause of death in the EU. The current leading specific molecular imaging diagnostic technique sensitive to cancer is based on Positron Emission Tomography (PET). Due to the high implementation cost of PET, this high-sensitivity diagnostics, is only available to less than 0,5 % of the medical centers in the world. The critical component of the overall cost is the cost of PET scanners. Our project proposes a radical vision to translate European breakthrough technological advances in Time-of-Flight PET detection to a revolutionary, fully modular, cost-accessible flexible family of devices for applications from the standard PET center to the surgery, epilepsy clinics, intensive care units and even emergency rooms and in mobile units installed in vans. The proposed PetVision project aims to develop a simple pilot demonstrator, a modular panel PET device with a coincidence timing resolution of about 75 ps FWHM, close to the intrinsic timing limit of currently available PET scintillators. This resolution is several times better than the current gold standard of 214 ps FWHM achieved with the current clinical state-of-the-art device (Siemens Biograph Vision). With such excellent timing, the panel detectors can cover only a limited solid angle to reach the same sensitivity or improve the sensitivity in the case of a total-body imager. For the realization of the device, a package of breakthrough innovations in detector design, photo-sensor, and front-end electronics are planned. We expect that the proposed device will dramatically impact human health.
ver más
Duración del proyecto: 59 meses
Fecha Inicio: 2023-09-01
Fecha Fin: 2028-08-31
Fecha Fin: 2028-08-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-09-01
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2022-PATHFINDEROPEN-01-01:
EIC Pathfinder Open 2022
Cerrada
hace 2 años
Presupuesto
El presupuesto total del proyecto asciende a
3M€
Líder del proyecto
INSTITUT JOZEF STEFAN
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5